These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 946943)
21. Sonographic assessment of ovarian and endometrial changes during long-term Norplant use and their correlation with hormonal levels. Shaaban MM; Segal S; Salem HT; Ghaneimah SA; Khalifa EA; Ahmed AG Fertil Steril; 1993 May; 59(5):998-1002. PubMed ID: 8486202 [TBL] [Abstract][Full Text] [Related]
22. [Steroids and the prediction of ovulation]. Audebert AJ; Emperaire JC; Ruffie A Contracept Fertil Sex (Paris); 1984 Feb; 12(2):411-9. PubMed ID: 12265829 [TBL] [Abstract][Full Text] [Related]
23. Inhibition of ovulation during discontinuous intranasal luteinizing hormone-releasing hormone agonist dosing in combination with gestagen-induced bleeding. Lemay A; Faure N; Labrie F; Fazekas AT Fertil Steril; 1985 Jun; 43(6):868-77. PubMed ID: 3158551 [TBL] [Abstract][Full Text] [Related]
24. Pituitary-ovarian function after tubal ligation. Alvarez-Sanchez F; Segal SJ; Brache V; Adejuwon CA; Leon P; Faundes A Fertil Steril; 1981 Nov; 36(5):606-9. PubMed ID: 7308505 [TBL] [Abstract][Full Text] [Related]
25. Inhibition of ovulation in women by chronic treatment with a stimulatory LRH analogue--a new approach to birth control? Nillius SJ; Bergquist C; Wide L Contraception; 1978 Jun; 17(6):537-45. PubMed ID: 352612 [TBL] [Abstract][Full Text] [Related]
26. Correlation between the serum norethindrone (NET) levels attained after insertion of a silastic implant releasing norethindrone acetate and the endogenous hormones particularly progesterone. Laumas V; Jain AK; Jha P; Rahman SA; Kumar D; Malik BK; Sarkar NN; Takkar D; Hingorani V; Laumas KR Contraception; 1981 Feb; 23(2):211-25. PubMed ID: 6786828 [TBL] [Abstract][Full Text] [Related]
27. [Simultaneous study of plasma gonadotropins, estrogens, progesterone and 17-hydroxyprogesterone during the ovulatory cycle]. Roger M; Veinante A; Soldat MC; Tardy J; Tribondeau E; Scholler R Nouv Presse Med; 1975 Sep; 4(30):2173-8. PubMed ID: 1178478 [TBL] [Abstract][Full Text] [Related]
28. Serum levels of FSH, LH, estradiol-17 beta and progesterone following the administration of a combined oral contraceptive containing 20 micrograms ethinylestradiol. Carlström K; Lunell NO; Zador G Gynecol Obstet Invest; 1978; 9(6):304-11. PubMed ID: 754992 [TBL] [Abstract][Full Text] [Related]
30. Experimental studies on the endocrine regulations during the periovulatory phase of the human menstrual cycle. The effects of exogenous 17 -oestradiol and progesterone on the release of pituitary luteinizing and follicle stimulating hormones. Leyendecker G; Wardlaw S; Nocke W Acta Endocrinol (Copenh); 1972 Sep; 71(1):160-78. PubMed ID: 4678011 [TBL] [Abstract][Full Text] [Related]
31. Some aspects on pituitary function in human and rat anovulatory cycles. Makino T; Shiina M; Ohno T; Iizuka R; Tamaoki B Endocrinol Jpn; 1976 Dec; 23(6):445-9. PubMed ID: 798684 [TBL] [Abstract][Full Text] [Related]
32. The prediction and/or detection of ovulation by means of urinary steroid assays. Cekan SZ; Beksac MS; Wang E; Shi S; Masironi B; Landgren BM; Diczfalusy E Contraception; 1986 Apr; 33(4):327-45. PubMed ID: 3731775 [TBL] [Abstract][Full Text] [Related]
34. Studies on ovarian and adrenal steroids at different phases of the menstrual cycle. 1. Dynamic changes during the periovulatory period. Aedo AR; Landgren BM; Diczfalusy E Contraception; 1981 Feb; 23(2):107-24. PubMed ID: 7238039 [TBL] [Abstract][Full Text] [Related]
35. Serum gonadotropin and steroid patterns during the normal menstrual cycle. Mishell DR; Nakamura RM; Crosignani PG; Stone S; Kharma K; Nagata Y; Thorneycroft IH Am J Obstet Gynecol; 1971 Sep; 111(1):60-5. PubMed ID: 5096358 [TBL] [Abstract][Full Text] [Related]
36. Inhibition of ovulation by progestin analogs (agonists vs antagonists): preliminary evidence for different sites and mechanisms of actions. Heikinheimo O; Gordon K; Williams RF; Hodgen GD Contraception; 1996 Jan; 53(1):55-64. PubMed ID: 8631191 [TBL] [Abstract][Full Text] [Related]
37. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin. Kekkonen R; Alfthan H; Haukkamaa M; Heikinheimo O; Luukkainen T; Lähteenmäki P Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063 [TBL] [Abstract][Full Text] [Related]
38. Direct radioimmunoassay of urinary estrogen and pregnanediol glucuronides during the menstrual cycle. Stanczyk FZ; Miyakawa I; Goebelsmann U Am J Obstet Gynecol; 1980 Jun; 137(4):443-50. PubMed ID: 7386528 [TBL] [Abstract][Full Text] [Related]
39. Effect of levonorgestrel-releasing intrauterine device on hormonal profile and menstrual pattern after long-term use. Xiao B; Zeng T; Wu S; Sun H; Xiao N Contraception; 1995 Jun; 51(6):359-65. PubMed ID: 7554977 [TBL] [Abstract][Full Text] [Related]
40. Experimental studies on the positive feedback effect of progesterone, 17 alpha-hydroxyprogesterone and 20 alpha-dihydroprogesterone on the pituitary release of LH and FSH in the human female. The estrogen priming of the progesterone feedback on pituitary gonadotropins in the eugonadal woman. Leyendecker G; Wildt L; Gips H; Nocke W; Plotz EJ Arch Gynakol; 1976; 221(1):29-45. PubMed ID: 989265 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]